<DOC>
	<DOC>NCT01845649</DOC>
	<brief_summary>The purpose of the study is to determine if WC3011 is safe and effective in treating the symptom of painful intercourse secondary to vulvovaginal atrophy as measured by subject self-assessment when compared to vehicle.</brief_summary>
	<brief_title>Study to Evaluate Safety &amp; Efficacy of WC3011 in Postmenopausal Women With Dyspareunia</brief_title>
	<detailed_description />
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Dyspareunia</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Sexually active with selfidentified dyspareunia (pain with sexual activity), at least moderate to severe &amp; most bothersome symptom of VVA (vulvovaginal atrophy) Postmenopausal &amp; meets 1 of the following: 12 months spontaneous amenorrhea, 6 months spontaneous amenorrhea with FSH (follicle stimulating hormone) &gt;40 mIU/mL,6 weeks postsurgical bilateral oophorectomy with confirmation by FSH &gt;40 mIU/mL, surgical report or ultrasound, 6 weeks postsurgical hysterectomy with ovary failure confirmed by FSH &gt;40 mIU/mL Age ≥40 years; ≥35 with bilateral oophorectomy Normal clinical breast exam or negative mammogram if ≥ 40 years of age Negative urine pregnancy test (nonhysterectomized &amp; &lt;12 months amenorrhea Enrollment Sponsor's Study PR04409 or PR05812 Participation in clinical trial or use of investigational drug within 30 days prior to screening Known hypersensitivity to estrogen &amp;/or progestin therapy Known or suspected premalignant or malignant disease or history steroiddependent malignancy Manifestation or treatment for significant cardiovascular disease (congestive heart failure, stroke or ischemic attack, myocardial infarction, coronary artery bypass, percutaneous angioplasty or &gt; 50% angiographic narrowing of coronary artery Thrombophlebitis or thromboembolic disorder or history of Insulindependent diabetes mellitus Increased frequency or severity of headaches while on hormone or estrogen therapy Currently taking St. John's Wort Drug/alcohol addiction within past 2 years Treatment with anticoagulants (heparin or warfarin) Smoking ≥15 cigarettes/day</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Vulvovaginal Atrophy</keyword>
	<keyword>Dyspareunia</keyword>
	<keyword>Postmenopausal</keyword>
</DOC>